Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / HEALTHCARE BUL
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
93,191
-
Shares change
-
+32,969
-
Total reported value, excl. options
-
$13,512,085
-
Value change
-
+$5,665,143
-
Put/Call ratio
-
90.23%
-
Number of buys
-
9
-
Number of sells
-
-14
-
Price
-
$144.96
Significant Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) as of Q4 2021
36 filings reported holding CURE - DIREXION SHS ETF TR - HEALTHCARE BUL as of Q4 2021.
DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 93,191 shares
.
Largest 10 shareholders include OLD MISSION CAPITAL LLC (28,685 shares), HRT FINANCIAL LP (19,609 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (17,335 shares), Traynor Capital Management, Inc. (7,989 shares), RENAISSANCE TECHNOLOGIES LLC (3,600 shares), Capital Investment Advisors, LLC (2,995 shares), CITADEL ADVISORS LLC (2,892 shares), MORGAN STANLEY (1,812 shares), WOLVERINE TRADING, LLC (1,724 shares), and SIMPLEX TRADING, LLC (1,403 shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.